secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001638833-23-000093
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q3 revenue up 8.6% to $674M; raises FY Adjusted EBITDA guidance to $436-440M
--------------------------------------------------------------------------------

- Revenues $674.1M (+8.6% YoY); net loss improved to $4.9M from $25M.
- Adjusted EBITDA $105.5M (+9.7% YoY); margin improved to 15.7%.
- Same-facility revenues up 14.2% (days adjusted); case volume +2.9%, revenue per case +11.0%.
- Full-year 2023 Adjusted EBITDA guidance raised to $436-440M; revenue ~$2.75B.
- Free Cash Flow of $63.2M in Q3; cash and revolver availability $781M total.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/0001638833-23-000093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/sgry-20231107.htm
  HTML page:      https://secwatch.observer/filing/0001638833-23-000093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer